申请人:Hallberg Anders
公开号:US20060183780A1
公开(公告)日:2006-08-17
There is provided a compound of formula (I), wherein R
1
, R
2
, R
3
, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
提供了一个式子为(I)的化合物,其中R1,R2,R3,X和Y的含义详见说明,并且其药学上可接受的盐,这些化合物在治疗需要抑制脂氧合酶(例如15-脂氧合酶)活性的疾病中非常有用,特别是在治疗炎症方面。